PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2023-02-04 (2)

Date Title Company
04-Feb-2023 U.S. FDA Approves Takeda‚Äôs TAKHZYRO® (lanadelumab-flyo) to Prevent Hereditary Angioedema (HAE) Attacks in Children 2 Years of Age and Older Businesswire